1332758-04-9

Basic information

• Product Name: 3-(benzyloxymethyl)-1-[2,3,5-tri-O-(tert-butyldimethylsilyl)-β-D-ribo-pentofuranosyl]uracil
• Synonyms: 3-(benzyloxymethyl)-1-[2,3,5-tri-O-(tert-butyldimethylsilyl)-β-D-ribo-pentofuranosyl]uracil
• CAS NO: 1332758-04-9
• Molecular Weight: 707.143
• Mol File: 1332758-04-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-(benzyloxymethyl)-1-[2,3,5-tri-O-(tert-butyldimethylsilyl)-β-D-ribo-pentofuranosyl]uracil(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(benzyloxymethyl)-1-[2,3,5-tri-O-(tert-butyldimethylsilyl)-β-D-ribo-pentofuranosyl]uracil(1332758-04-9)
• EPA Substance Registry System: 3-(benzyloxymethyl)-1-[2,3,5-tri-O-(tert-butyldimethylsilyl)-β-D-ribo-pentofuranosyl]uracil(1332758-04-9)

Safety Data

• Hazardous Substances Data: 1332758-04-9(Hazardous Substances Data)

Upstream product

• 3587-60-8 Benzyloxymethyl chloride 
• 64898-15-3 2',3',5'-tris-O-(tert-butyldimethylsilyl)uridine 

Downstream Products

• 1332758-11-8 3-(benzyloxymethyl)-1-[2,3-di-O-(tert-butyldimethylsilyl)-4,5-dehydro-5-deoxy-β-D-ribopentofuranosyl]uracil 
• 1332757-98-8 (Z)-3-(benzyloxymethyl)-1-[2,3-di-O-(tert-butyldimethylsilyl)-4,5-dehydro-5-deoxy-5-iodo-β-D-ribopentofuranosyl]uracil 
• 1332758-07-2 3-(benzyloxymethyl)-1-[2,3-di-O-(tert-butyldimethylsilyl)-β-D-ribo-pentofuranosyl]uracil 
• 1332758-09-4 3-(benzyloxymethyl)-1-[2,3-di-O-(tert-butyldimethylsilyl)-5-deoxy-5-iodo-β-D-ribopentofuranosyl]uracil 
• 1346620-43-6 C₄₄H₇₅N₅O₁₀Si₂ 
• 1346620-33-4 C₄₄H₇₅N₅O₁₀Si₂ 
• 1346620-42-5 C₃₈H₆₄N₄O₉Si₂ 
• 1346620-32-3 C₃₈H₆₄N₄O₉Si₂ 
• 1346620-41-4 C₂₂H₂₇N₅O₁₀ 
• 1346620-31-2 C₂₂H₂₇N₅O₁₀ 
• 1346620-40-3 C₃₄H₅₅N₅O₁₀Si₂ 
• 1346620-30-1 C₃₄H₅₅N₅O₁₀Si₂ 
• 1346620-36-7 C₄₃H₆₅N₃O₁₀Si₂ 
• 1346620-25-4 C₄₃H₆₅N₃O₁₀Si₂ 

Relevant articles and documents

Total synthesis of pacidamycin D by Cu(I)-Catalyzed oxy enamide formation

The first total synthesis of pacidamycin D, which is expected to be a good candidate as an antibacterial agent against P. aeruginosa, is described. The key elements of our approach feature an efficient and stereocontrolled construction of the Z-oxyvinyl iodide and copper-catalyzed crosscoupling with the tetrapeptide carboxamide.